Finance

Lists
300871:SHE
Wuhan Hvsen Biotechnology Co Ltd
CNÂ¥22.59
-1.14%
(-0.26) 1D
Sep 9, 3:04:13 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300871...
Open
CNÂ¥22.85
High
CNÂ¥23.00
Low
CNÂ¥22.50
Mkt. cap
4.65B
Avg. vol.
5.53M
Volume
3.50M
Dividend
2.21%
Quarterly dividend
CNÂ¥0.12
Ex-dividend date
Jul 6, 2026
P/E ratio
13.68
52-wk high
CNÂ¥32.62
52-wk low
CNÂ¥19.08
EPS
CNÂ¥1.65
Shares outstanding
201.78M
No. of employees
1K
Open
CNÂ¥22.85
High
CNÂ¥23.00
Low
CNÂ¥22.50
Mkt. cap
4.65B
Avg. vol.
5.53M
Volume
3.50M
Dividend
2.21%
Quarterly dividend
CNÂ¥0.12
Ex-dividend date
Jul 6, 2026
P/E ratio
13.68
52-wk high
CNÂ¥32.62
52-wk low
CNÂ¥19.08
EPS
CNÂ¥1.65
Shares outstanding
201.78M
No. of employees
1K
About Wuhan Hvsen Biotechnology Co Ltd
CEO-
Employees1.13K
FoundedJan 25, 2002
Headquarters-
SectorPharmaceutical industry
Websitewhhsyy.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
437.33M
421.71M
458.22M
406.71M
Cost of goods sold
291.81M
272.85M
295.49M
263.77M
Cost of revenue
291.81M
272.85M
295.49M
263.77M
Research and development expenses
22.49M
25.79M
24.40M
29.37M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
37.97M
46.04M
40.32M
41.37M
Operating expense
51.63M
86.98M
67.51M
74.25M
Total operating expenses
343.44M
359.83M
363.01M
338.01M
Operating income
93.90M
61.89M
95.21M
68.70M
Other non operating income
-2.21M
-354.51K
927.61K
-4.63M
EBT including unusual items
81.01M
74.07M
87.34M
146.26M
EBT excluding unusual items
92.63M
63.52M
97.69M
61.63M
Income tax expense
10.07M
9.06M
9.10M
18.06M
Effective tax rate
12.44%
12.24%
10.41%
12.35%
Other operating expenses
-12.11M
14.44M
711.37K
4.69M
Net income
70.72M
65.25M
77.67M
128.09M
Net profit margin
16.17%
15.47%
16.95%
31.49%
Earnings per share
-
-
-
-
Interest and investment income
2.02M
4.30M
1.55M
30.40K
Interest expense
-512.99K
-1.48M
-
-75.19K
Net interest expenses
1.50M
2.82M
1.55M
-44.79K
Depreciation and amortization charges
-
-
-
-
EBITDA
122.18M
91.96M
125.29M
100.14M
Gain or loss from assets sale
-
-
-
-51.32M
AI content may include mistakes. Learn more
Google apps